Skip to main content
. 2018 Jan 3;3(3):242–246. doi: 10.1001/jamacardio.2017.4873

Table. Associations of Long-Chain Acylcarnitines With Left Ventricular Structure and Function.

Characteristics Unadjusted Adjusted
Multivariablea Fullb
β (95% CI) P Value β (95% CI) P Value β (95% CI) P Value
Left ventricular mass index
C16 18.04 (6.47 to 29.62) .003 18.17 (5.33 to 31.01) .007 19.24 (5.48 to 33.01) .008
C18:1 24.52 (14.21 to 34.84) <1.0 × 10-4 25.44 (14.16 to 36.72) <1.0 × 10-4 26.18 (14.04 to 38.32) 1.0 × 10-4
C18:2 16.78 (4.90 to 28.66) .007 17.09 (4.21 to 29.96) .01 17.42 (3.40 to 31.43) .02
C18 20.66 (9.52 to 31.80) 6.0 × 10-4 17.14 (7.58 to 26.70) 9.0 × 10-4 25.25 (10.91 to 39.58) .001
C26 15.44 (3.41 to 27.47) .01 18.04 (3.76 to 32.32) .0147 19.93 (4.41 to 35.45) .01
Left ventricular ejection fraction
Choline −7.29 (−12.11 to 2.47) .004 −6.39 (−12.38 to 0.40) .04 −4.50 (−10.46 to 1.45) .13
Kynurenine −7.99 (−12.70 to 3.27) .001 −7.94 (−14.61 to 1.28) .02 −3.31 (−11.42 to 4.79) .41
C18:2 −6.88 (−11.76 to 2.00) .007 −6.97 (−11.95 to −1.99) .007 −6.11 (−10.88 to −1.34) .01
Relative wall thickness
C26 0.05 (0.01 to 0.09) .01 0.04 (−0.01 to 0.08) .11 NAc NAc

Abbreviation: NA, not applicable.

a

Adjusted for age, sex, diabetes status, and estimated glomerular filtration rate.

b

Further adjustment includes B-type natriuretic peptide.

c

Since C26 did not associate significantly after partial statistical analysis, additional adjustment and testing was inappropriate.